Az előadó: Ábel György,
Az előadás címe: “Genomika és célzott terápia: kitekintés a jövőbe”
Az előadóról: Dr. Gyorgy Abel is the Director of Clinical Chemistry, Molecular Diagnostics, and Immunology at the Lahey Hospital & Medical Center in Burlington, Massachusetts. He also serves as Clinical Instructor in Pathology at Harvard Medical School. Dr. Abel is board certified in Clinical Pathology (American Board of Pathology) and Molecular Diagnostics (DABCC), and is a Fellow of the College of American Pathologists (CAP), the National Academy of Clinical Biochemistry (NACB), and the Royal Society of Medicine (UK). He has over twenty-five years of experience in molecular biology and diagnostics. His clinical and research interests include the molecular pathology of hepatitis C infection, minimal residual disease detection in cancer, and personalized medicine. Dr. Abel previously served as Vice President of the American Board of Clinical Chemistry. Currently, he is a member of the Genomic Analysis Resource Guide Work Group of the College of American Pathologists (CAP), the Clinical and Translational Research Subcommittee of the Federation of American Societies for Experimental Biology (FASEB), the Clinical Immunology Committee of the American Association of Immunologists (AAI), and the Clinical Advisory Committee of the Reference Material Institute for Clinical Chemistry Standards (ReCCS) in Japan. Dr. Abel is the author or co-author of approximately 100 peer reviewed articles, book chapters, and scientific conference presentations. He frequently speaks nationally on current issues in clinical pathology and molecular diagnostics.
Az előadásról: Promo video
Az előadás nyelve magyar.